Faculty
Oncology Division

Ramaswamy Govindan, MD
Anheuser Busch Endowed Chair in Medical Oncology
Associate Chief, Division of Oncology
Professor
Department of Medicine
Oncology Division
Medical Oncology
Research Interests
- Lung cancer
- Cancer genomics
- Lung cancer
- Cancer genomics
Contact
- 314-747-7405 (office)
- 314-362-3895 (fax)
- rgovindan@wustl.edu
- Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid Campus Center (office)
Biosketch
Education | |
---|---|
1986 | MBBS, University of Madras, India |
1990 | MD, University of Pondicherry, India |
Post-graduate Training | |
1987-1990 | Resident, Internal Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, India |
1990-1991 | Chief Resident, Jawaharlal Institute of Postgraduate Medical Education and Research, India |
1991-1993 | Intern and Resident, Internal Medicine, Michael Reese Hospital and Medical Center, Chicago, IL |
1993-1996 | Fellow, Hematology/Oncology, Washington University, Department of Internal Medicine, St. Louis, MO |
Academic Positions & Employment | |
1996-1998 | Attending Physician, Department of Medicine, Cook County Hospital, Chicago, IL |
1998-2003 | Assistant Professor, Department of Medicine, Washington University Medical School, St. Louis, MO |
2003-2009 | Associate Professor, Department of Medicine, Washington University Medical School, St. Louis, MO |
2010-present | Professor, Department of Medicine, Washington University Medical School, St. Louis, MO |
2010-2015 | Co-Director, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University, St Louis, MO |
2015-present | Director, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University, St Louis, MO |
2022-present | Associate Chief, Division of Oncology, Department of Medicine, Washington University, St Louis, MO |
University & Hospital Appointments & Committees | |
1999-2007 | Member, Cancer Committee, Barnes-Jewish Hospital |
2000-2004 | Member, Education Subcommittee, Barnes-Jewish Hospital Cancer Committee |
2001-2004 | Chairman, Education Subcommittee, Barnes-Jewish Hospital Cancer Committee, Siteman Cancer Center |
2005-present | Member, Protocol Review and Monitoring Committee |
2008-present | Member, Human Research Protection Organization |
2010-present | Member, Protocol Adherence Review Committee, Washington University School of Medicine |
2010-present | Member, Committee on Admissions, Washington University School of Medicine |
2010-present | Member, Barnes-Jewish Hospital Expansion Committee |
2018-present | Member, Department of Surgery Ad Hoc Committee |
2018-present | Member, Washington University IRB/HRPO Advisory Committee |
2019-present | Member, Siteman Cancer Center External Advisory Committee |
2019-present | Member, Developmental Therapeutics Core Committee |
Board Certification | |
1993 | American Board of Internal Medicine |
1996 | American Board of Internal Medicine (Hematology) |
1997, 2008 | American Board of Internal Medicine (Medical Oncology) |
Honors & Awards | |
1993 | Alfred Pick Award for academic excellence during the Internal Medicine Residency at Michael Reese Hospital and Medical Center, Chicago, IL |
2001 | ASCO Clinical Research Career Development Award for research titled "A Pilot Study of Celecoxib in Patients with Barrett's Esophagus" |
2016 | Anheuser Busch Endowed Chair in Medical Oncology |
2016 | Alton Ochsner Award Related Smoking and Disease |
2020 | AACR Team Science Award |
Editorial Responsibilities | |
1999-present | ASCO Training Program Committee, Reading Syllabus on ASCO website |
2002 | Washington Manual of Oncology, Lippincott, Williams & Wilkins |
2004 | Locally Advanced Non-small Cell Lung Cancer: A Practical Management Guide, a COAB publication |
2005 | DeVita, Hellman & Rosenberg's "Cancer, Principles & Practice of Oncology Review", Lippincott Williams & Wilkins |
2006 | Locally Advanced Non-Small-Cell Lung Cancer: Cancer Management: a Multidisciplinary Approach, CMP United Business Media/Publishers of Oncology |
2006-2011 | ASCO Educational Book |
2007 | Washington Manual of Oncology, 2nd Edition, Lippincott, Williams & Wilkins |
2007 | E-Update Series- Non-small Cell Lung Cancer, CMP Media |
2008 | E-Update Series- Non-small Cell Lung Cancer, CMP Media |
2008-2011 | ASCO Meeting Summaries |
2008-present | Proceedings of the Annual Targeted Therapy Meeting Summary, International Association for the Study of Lung Cancer (ISLAC) |
2009 | DeVita, Hellman & Rosenberg's "Cancer, Principles & Practice of Oncology Review" 2nd Edition, Lippincott Williams & Wilkins |
2009 | Lung Cancer, Monograph, Lippincott, Williams & Wilkins |
2009-present | Clinical Care Options InPractice Oncology |
2010-present | Cancer Pharmacology, Lippincott, Williams & Wilkins |
2010-present | Oncology Advisory Editor, Oncology Times |
2015 | Washington Manual of Oncology, 3rd Edition, Lippincott, Williams & Wilkins |
Contemporary Oncology (bi-weekly newsletter/journal), Lippincott, Williams & Wilkins, Co-editor: Michael C. Perry | |
Thoracic Oncology Matters (quarterly), Washington University School of Medicine | |
International & National Committee Memberships | |
1998-2001 | Member, Oncology Training Program Committee, American Society of Clinical Oncology (ASCO) |
2000 | Member, Quality Assurance Subcommittee, Radiation Therapy Oncology Group (RTOG) |
2000-2007 | Co-Chair, Lung Committee, Hoosier Oncology Group (HOG) |
2000-present | Member, Lung Committee, Hoosier Oncology Group (HOG) |
2000-present | Member, Lung Steering Committee, Radiation Therapy Oncology Group (RTOG) |
2001-present | Member, Respiratory Core Committee, Cancer and Leukemia Group B (CALGB) |
2002-2005 | Vice-Chair, Midwest Oncology Group (MOG) |
2002-present | Member, Clinical Oncology Advisory Board (COAB) |
2003 | Reviewer for Cancer Research UK (formerly ICRS and CRC) Phase I and II protocols |
2004-2006 | Member, Lung Cancer Program Committee, American Society of Clinical Oncology |
2005-2007 | Chair, Lung Committee (P2C-Mayo Consortium) |
2007-2008 | Member (ad hoc), NCI SPORE Review Panel |
2007-present | Member, NCCN Guidelines Committee, Non-Small Cell Lung Cancer |
2008-present | Member, Cancer Center Review Panel, NCI |
2008-present | Member, American College of Surgical Oncology (ACOSOG) |
2008-present | Member, Education Committee, ASCO |
2009 | Vice Chair, Medical Oncology Committee, American College of Surgical Oncology (ACOSOG) |
2009 | Member, Review Panel, American Recovery Reinvestment Act (ARRA) |
2009-present | Member, Subcommittee H, NCI |
2009-present | Member, IASLC Pathology Committee |
2010 | Member (ad hoc), NCI Basic, Translational and Clinical Oncology Special Emphasis Panel |
2010-present | Co-Chair, Lung Cancer Disease Working Group, The Cancer Genome Atlas Project |
2012-present | Chair, IASLC CME Subcommittee |
2013-present | Member, National Comprehensive Cancer Network (NCCN) National Cancer Institute (NCI) Non-Small Cell Lung Cancer Panel |
2014-present | Member, SITC/Medscape CME Project Steering Committee |
2014-present | Member, ALCHEMIST Champions Team |
2014 | Member, International Association for the Study of Lung Cancer Core Program Committee for the Treatment of Localized Disease NSCLC Track |
2018-present | Member, AACR Lung Cancer Research Fellowships Scientific Review Committee |
2018-present | Member, ALCHEMIST Core Committee |
2018-present | Member, K12 External Advisory Committee |
2018-present | Member, PDX Steering Committee |
2018-present | Co-Chair, SITC Lung Subcommittee |
2018-present | Member, SITC Cancer Immunotherapy Guidelines (CIG) Committee |
2019-present | Member, The Cancer Genoma Atlas Lung Adenocarcimona Subgroup (TCGA LUAD) NIH/NCI |
2019-present | Member, PierianDx Knowledgebase Expert Panel |
2019 | Member, Dr. Dubinett’s CLIN2-10784 Clinical Advisory Panel |